Lymphoid Hematologic Malignancy
📧 Sign up to get email alerts when something new happens for Lymphoid Hematologic Malignancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial of ixazomib to prevent recurrent or late acute and chronic graft-versus-host disease after allogeneic stem cell trans…